Mindray: robust overseas sales

Background:Mindray Medical International (MR:NYSE) is a Shenzhen-based medical device manufacturer, offering more than 40 products across three business segments including patient monitoring devices and life support machines, invitro diagnostic instruments and medical imaging systems. The company has sold its products to over 40,000 hospitals, clinics, and healthcare centres across China and exports to 190 countries including Europe, the US and emerging markets. The company invests around 10% of annual sales into research and development.

China Confidential Funds

China Confidential Funds, a new research service launched by FT China Confidential, is dedicated to illuminating the mainland fund industry. Our team of fund industry experts in Shanghai search out the interesting trends in fund performance, strategy, interactions with overseas funds, regulatory changes, distribution and management. We also use a proprietary system to track the emerging flows of Chinese money. Click here to find out more.

Other Articles on this Issue

• Financial China

  Is China headed for a perfect financial storm?

  Select financial charts

• Macro View

  A-share distress

• Consumer China

  Medical devices – in the pink

  Weigao: climbing the value chain

  Beijing Wandong: seeking solace in rural demand

  Shinva: on the acquisition trail

  Lepu: bringing heart technology to lower tier cities

• Funds Data

  China flows go cold

• The Best of Chinese Commentators

  A-share slide

  Falling property prices to hurt local government finances?

• The Big Call

  Real estate prices start to fall

• Capital Intensive China

  Cooling property market to depress steel prices

• Guest Column

  China's new growth model – does it work?

• View issue